Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis.

Schaudt A, Kriener S, Schwarz W, Wullstein C, Zangos S, Vogl T, Mehrabi A, Fonouni H, Bechstein WO, Golling M.

Clin Transplant. 2009 Dec;23 Suppl 21:61-7. doi: 10.1111/j.1399-0012.2009.01111.x.

PMID:
19930318
2.

Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.

Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W.

Liver Transpl. 2003 Jun;9(6):557-63.

3.
4.

Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.

Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Boudjema K, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Dhumeaux D, Cherqui D, Duvoux C.

Liver Transpl. 2005 Jul;11(7):767-75.

5.

Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis.

Lesurtel M, Müllhaupt B, Pestalozzi BC, Pfammatter T, Clavien PA.

Am J Transplant. 2006 Nov;6(11):2644-50. Epub 2006 Aug 25. Review.

6.

Transarterial chemoembolization for HCC in patients with extensive liver transplantation waiting times.

Eswaran SL, Pierce K, Weaver F, Rogers T, Brems JJ, Sontag SJ, Borge M.

Angiology. 2012 Apr;63(3):206-12. doi: 10.1177/0003319711411705. Epub 2011 Jul 6.

PMID:
21733955
7.

Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study.

Veltri A, Grosso M, Martina MC, Ciancio A, David E, Salizzoni M, Soldano U, Galli J, Fava C.

Cardiovasc Intervent Radiol. 1998 Sep-Oct;21(5):393-8.

PMID:
9853145
8.

Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.

Wong LL, Tanaka K, Lau L, Komura S.

Clin Transplant. 2004 Jun;18(3):227-34.

PMID:
15142041
9.

Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival.

Bharat A, Brown DB, Crippin JS, Gould JE, Lowell JA, Shenoy S, Desai NM, Chapman WC.

J Am Coll Surg. 2006 Oct;203(4):411-20. Epub 2006 Aug 17.

PMID:
17000383
10.

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.

Otto G, Herber S, Heise M, Lohse AW, Mönch C, Bittinger F, Hoppe-Lotichius M, Schuchmann M, Victor A, Pitton M.

Liver Transpl. 2006 Aug;12(8):1260-7.

11.

Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation.

Fisher RA, Maroney TP, Fulcher AS, Maluf D, Clay JA, Wolfe LG, Dawson S 3rd, Cotterell A, Stravitz RT, Luketic VA, Shiffman M, Sterling RK, Posner MP.

Clin Transplant. 2002;16 Suppl 7:52-8.

PMID:
12372045
12.

Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?

Pérez Saborido B, Meneu JC, Moreno E, García I, Moreno A, Fundora Y.

Am J Surg. 2005 Sep;190(3):383-7.

PMID:
16105523
13.

Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.

Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD, Lowell JA, Shenoy S, Darcy MD, Brown DB.

Ann Surg. 2008 Oct;248(4):617-25. doi: 10.1097/SLA.0b013e31818a07d4.

PMID:
18936575
14.

Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.

Moreno Planas JM, López Monclús J, Gómez Cruz A, Rubio González E, Pérez Arangüena R, Boullosa Graña E, Garcia Suárez A, Pérez-Picouto JL, Fernández Ruiz M, Lucena de la Poza JL, Sánchez Turrión V, Cuervas-Mons Martínez V.

Transplant Proc. 2005 Apr;37(3):1484-5.

PMID:
15866648
16.

Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.

Heckman JT, Devera MB, Marsh JW, Fontes P, Amesur NB, Holloway SE, Nalesnik M, Geller DA, Steel JL, Gamblin TC.

Ann Surg Oncol. 2008 Nov;15(11):3169-77. doi: 10.1245/s10434-008-0071-3. Epub 2008 Aug 12.

PMID:
18696158
17.

Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.

Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW.

Hepatology. 2005 May;41(5):1130-7.

PMID:
15841454
18.

Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.

Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.

Liver Transpl. 2004 Dec;10(12):1478-86.

19.

Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma.

Otto G, Heise M, Moench C, Herber S, Bittinger F, Schuchmann M, Hoppe-Lotichius M, Pitton M.

Transplant Proc. 2007 Mar;39(2):537-9.

PMID:
17362776
20.

Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.

Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.

J Nucl Med. 2009 Jun;50(6):871-7. doi: 10.2967/jnumed.108.060558. Epub 2009 May 14.

Supplemental Content

Support Center